A therapeutic vaccine targeting HPV16 induced regression in high-grade precancerous cervical lesion. If left untreated, one-third progress to cervical cancer in 10 years and half in 30 years. At least half of patients with precancerous lesions may be able to omit surgery and its complications.
Read Full Article
#HPVCancerAwareness #CervicalHealth #VaccinationForPrevention #TherapeuticVaccine #WomensHealth
Read Full Article
#HPVCancerAwareness #CervicalHealth #VaccinationForPrevention #TherapeuticVaccine #WomensHealth
American Association for Cancer Research (AACR)
A Therapeutic HPV Vaccine Could Eliminate Precancerous Cervical Lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published in Clinical Cancer Research, a journal of the American Association…
👏1